PP
FMTX

PDT Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

PDT Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,063
Closed -$580K – 972
2022
Q3 		$580K Sell
29,063
-77,601
-73% -$1.02M 0.09% 395
2022
Q2 		$735K Buy
106,664
+18,697
+21% +$131K 0.06% 492
2022
Q1 		$818K Buy
+87,967
New +$936K 0.07% 432

PDT Partners's FMTX Position: Q4 2022 in Review

PDT Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 29,063 shares — an estimated $580K sold.

PDT Partners first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $818K in Q1 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • PDT Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 29,063 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $580K.
  • PDT Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • PDT Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $818K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.